Status:
UNKNOWN
TMD Pulsed Radiofrequency
Lead Sponsor:
McGill University Health Centre/Research Institute of the McGill University Health Centre
Conditions:
Temporomandibular Joint Pain
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
PRF of the masticatory muscles (masseter, temporalis, medial and lateral pterygoid muscle) can improve pain intensity and functional recovery of the jaw in patients with extra-articular TMD.
Detailed Description
The temporomandibular joint is formed by the mandibular condyle inserting into the mandibular fossa of the temporal bone. Muscles of mastication are primarily responsible for the movement of this join...
Eligibility Criteria
Inclusion
- Thirty consecutive patients, male and female, between 18 and 80 years old, with extra-articular TMD as diagnosed by a specialist of the Maxillofacial team based on Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) for Clinical and Research Applications, with chronic pain related to TMD (for more than three months according to IASP definition), and who have plateaued with conventional treatment in the past three months, will be prospectively recruited at the Maxillofacial Surgery Clinic
Exclusion
- • Patients younger than 18 years old.
- ASA physical status \>3,
- Contraindication for local anesthetics or RF.
- Immunosuppression or high risk of infection.
- Coagulation impairment.
- Patients with psychiatric illness.
- Patients with cognitive impairment.
- Patients currently taking opioids.
- Patients that had botulinum toxin or steroid injections in the head or neck area in the past three months.
- Patient with pacemaker.
- Patient with prosthetic joint replacement, or placement of any metallic surgical device in or around the area of treatment.
- Infection of the TMJ.
- Muscular dystrophy.
- Pathology or impaired masticatory muscles.
- Pregnancy.
- Autoimmune diseases.
- Arthralgia or intra-articular joint dysfunction.
- Patients with allergy to Cefazolin.
Key Trial Info
Start Date :
March 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03848169
Start Date
March 1 2018
End Date
December 31 2019
Last Update
February 20 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Montreal General Hospital
Montreal, Quebec, Canada, H3A 1A1